Market Cap | ₹11,281Cr |
ROE | 77.82% |
P/E Ratio(TTM) | 56.40 |
EPS(TTM) | 86.84 |
P/B Ratio | 43.89 |
Dividend Yield | 1.12% |
Industry P/E | 38.99 |
Book Value | 111.60 |
Debt to Equity | 0.11 |
Face Value | 10 |
Parent Organisation | Sanofi Consumer Healthcare India |
NSE Symbol | SANOFICONR |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Abbott India | NA (0.00%) | 43.54 | ||
GlaxoSmithKline Pharmaceuticals | NA (0.00%) | 47.61 | ||
Pfizer | NA (0.00%) | 27.90 | ||
Astrazeneca Pharma India | NA (0.00%) | 120.25 |